60 related articles for article (PubMed ID: 5043227)
1. Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent.
Lintrup J; Hyltoft-Petersen P; Knudtzon S; Nissen NI
Cancer Chemother Rep; 1972 Apr; 56(2):229-35. PubMed ID: 5043227
[No Abstract] [Full Text] [Related]
2. Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent.
Knudtzon S; Nissen NI
Cancer Chemother Rep; 1972 Apr; 56(2):221-7. PubMed ID: 4557737
[No Abstract] [Full Text] [Related]
3. Effect of acidification on protein binding of mycophenolic acid.
Ting LS; Decarie D; Ensom MH
Ther Drug Monit; 2007 Feb; 29(1):132-3. PubMed ID: 17304164
[No Abstract] [Full Text] [Related]
4. The metabolism and binding of ( 14 C)mycophenolic acid in the rat.
Nery R; Nice E
J Pharm Pharmacol; 1971 Nov; 23(11):842-7. PubMed ID: 4400192
[No Abstract] [Full Text] [Related]
5. Mycophenolic acid (NSC-129185): preliminary clinical trials.
Brewin TB; Cole MP; Jones CT; Platt DS; Todd ID
Cancer Chemother Rep; 1972 Feb; 56(1):83-7. PubMed ID: 4557035
[No Abstract] [Full Text] [Related]
6. The disposition of the antitumor agent, sangivamycin, in mice.
Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic profile of mycophenolic acid in piglets after small bowel transplantation.
Iacona I; Regazzi MB; Spada M; Villani P; Molinaro M; Alessiani M
Transplant Proc; 1996 Oct; 28(5):2525-6. PubMed ID: 8907934
[No Abstract] [Full Text] [Related]
8. Experimental antitumor activity and preclinical toxicology of mycophenolic acid.
Sweeney MJ; Gerzon K; Harris PN; Holmes RE; Poore GA; Williams RH
Cancer Res; 1972 Sep; 32(9):1795-802. PubMed ID: 4509039
[No Abstract] [Full Text] [Related]
9. Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells.
Franklin TJ; Jacobs V; Jones G; Plé P; Bruneau P
Cancer Res; 1996 Mar; 56(5):984-7. PubMed ID: 8640790
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Patel CG; Harmon M; Gohh RY; Akhlaghi F
Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
[TBL] [Abstract][Full Text] [Related]
11. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
12. Pharmacological and biochemical effects of pyrazofurin in humans.
Ohnuma T; Roboz J; Shapiro ML; Holland JF
Cancer Res; 1977 Jul; 37(7 Pt 1):2043-9. PubMed ID: 861933
[No Abstract] [Full Text] [Related]
13. Metabolism and biochemistry of mycophenolic acid.
Sweeney MJ; Hoffman DH; Esterman MA
Cancer Res; 1972 Sep; 32(9):1803-9. PubMed ID: 4629779
[No Abstract] [Full Text] [Related]
14. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076
[TBL] [Abstract][Full Text] [Related]
15. Human colorectal carcinoma cells in vitro as a means to assess the metabolism of analogs of mycophenolic acid.
Franklin TJ; Jacobs VN; Jones G; Ple P
Drug Metab Dispos; 1997 Mar; 25(3):367-70. PubMed ID: 9172956
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report of the distribution of [14C]penicillic acid in rats: autoradiographic technique.
Park DL; Miller E; Heath JL
Am J Vet Res; 1978 Nov; 39(11):1863-5. PubMed ID: 736347
[TBL] [Abstract][Full Text] [Related]
17. A spectrophotometric method for the estimation of the carcinostatic agent, 5-aziridino-2,4-dinitrobenzamide (CB 1954), in biological fluids.
Ross WC
Biochem Pharmacol; 1969 Oct; 18(10):2683-8. PubMed ID: 5404002
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.
Comis RL; Griffin TW; Raso V; Ginsberg SJ
Cancer Res; 1979 Mar; 39(3):757-61. PubMed ID: 154969
[No Abstract] [Full Text] [Related]
19. ORAL ADMINISTRATION OF VINBLASTINE SULFATE (NSC-49842) TO CANCER PATIENTS.
KORST DR; NIXON JC
Cancer Chemother Rep; 1965 Apr; 45():53-6. PubMed ID: 14328049
[No Abstract] [Full Text] [Related]
20. A micellar electrokinetic capillary chromatography method for monitoring mycophenolic acid in serum of transplant recipients.
Suntornsuk L; Meyer T; Lindgren A; Frahm AW
Pharmazie; 2005 Feb; 60(2):115-9. PubMed ID: 15739899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
